Cargando…
Prenatal Cannabinoid Exposure: Emerging Evidence of Physiological and Neuropsychiatric Abnormalities
Clinical reports of cannabis use prevalence during pregnancy vary widely from 3% to upwards of 35% in North America; this disparity likely owing to underestimates from self-reporting in many cases. The rise in cannabis use is mirrored by increasing global legalization and the overall perceptions of...
Autores principales: | Nashed, Mina G., Hardy, Daniel B., Laviolette, Steven R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841012/ https://www.ncbi.nlm.nih.gov/pubmed/33519564 http://dx.doi.org/10.3389/fpsyt.2020.624275 |
Ejemplares similares
-
Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders
por: Ishiguro, Hiroki, et al.
Publicado: (2022) -
The Role of Cannabinoid Transmission in Emotional Memory Formation: Implications for Addiction and Schizophrenia
por: Tan, Huibing, et al.
Publicado: (2014) -
Prenatal Drug Exposure in Children With a History of Neuropsychiatric Care: A Nested Case-Control Study
por: Benevent, Justine, et al.
Publicado: (2022) -
Cannabinoid as Beneficial Replacement Therapy for Psychotropics to Treat Neuropsychiatric Symptoms in Severe Alzheimer’s Dementia: A Clinical Case Report
por: Defrancesco, Michaela, et al.
Publicado: (2020) -
Effects of Adolescent THC Exposure on the Prefrontal GABAergic System: Implications for Schizophrenia-Related Psychopathology
por: Renard, Justine, et al.
Publicado: (2018)